Every 2 years, researchers from the American Cancer Society (ACS) publish a comprehensive report using data from multiple ...

In fact, 25 percent of cervical cancer diagnoses occur in women over the age of 65, and cervical cancers diagnosed in this ...

Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets ...

In a promising advancement for cancer care, doctors at AIIMS Delhi have developed a new blood test that could assist in keeping track of whether a cervical treatment is working or if the disease ...

They found fragments of the DNA of human papillomavirus (HPV) — the virus responsible for the vast majority of cervical cancer cases — circulating in the blood, with their levels correlating with the ...

Published in Scientific Reports, the study shows that detecting cell-free HPV DNA in blood can serve as a reliable marker to monitor therapy response in cervical cancer patients, both before and ...

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas, April 10, 2025 – A cancer patient at Brooke Army Medical Center was able to celebrate two significant events in one day. Linda Staggers rang the ...

One in two cancer patients report being afraid to share their diagnosis with employers, according to research from Working With Cancer, a global initiative co-founded by the Publicis Foundation and ...

Treatment for cervical cancer depends on its stage and other factors like the patient's age and desire ... can be delivered externally or internally (brachytherapy), while chemotherapy drugs ...

The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have ...

In this article, Jasveen Chugh discusses how patient-centric healthcare can only work if pharma companies really understand who the customer is. She also looks at how it requires innovative ...

The researchers found that the model was up to 81% accurate at discerning plasma samples from patients with lung cancer compared with those from individuals without the disease.